Breast Cancer
Reports from the United Kingdom and United States describe recent advances in breast cancer research
Published in Women's Health Weekly, May 8th, 2006
Study 1: Scientists analyzed the outcome following neoadjuvant chemotherapy for breast carcinoma.
According to a study from England, "Patients who have no residual invasive cancer following neoadjuvant chemotherapy for breast carcinoma have a better overall survival than those with residual disease. Many classification systems assessing pathological response to neoadjuvant chemotherapy include residual ductal carcinoma in situ (DCIS) only in the definition of pathological complete response."
"The purpose of this study was to investigate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Behavioral Medicine
Cortical thickness differences in men and women may influence gender-specific abilities - Breast Cancer
Breast screening radiation has been re-evaluated for risk estimate based on current data - Coronary Heart Disease
Risk of sudden cardiac death in women may be reduced by regular physical exercise - Obesity Surgery
Weight loss after laparoscopic adjustable gastric banding improves metabolic profile - Substance Abuse
Alcohol and substance abuse relapse reveals gender responses to interpersonal problems - Apoptosis
Reports from India, Iran and Australia describe recent advances in apoptosis research - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
